Increasing histone acetylation improves sociability and restores learning and memory in KAT6B-haploinsufficient mice
Maria I. Bergamasco, Hannah K. Vanyai, Alexandra L. Garnham, Niall D. Geoghegan, Adam P. Vogel, Samantha Eccles, Kelly L. Rogers, Gordon K. Smyth, Marnie E. Blewitt, Anthony J. Hannan, Tim Thomas, Anne K. Voss
Maria I. Bergamasco, Hannah K. Vanyai, Alexandra L. Garnham, Niall D. Geoghegan, Adam P. Vogel, Samantha Eccles, Kelly L. Rogers, Gordon K. Smyth, Marnie E. Blewitt, Anthony J. Hannan, Tim Thomas, Anne K. Voss
View: Text | PDF
Research Article Development Genetics

Increasing histone acetylation improves sociability and restores learning and memory in KAT6B-haploinsufficient mice

Abstract

Mutations in genes encoding chromatin modifiers are enriched among mutations causing intellectual disability. The continuing development of the brain postnatally, coupled with the inherent reversibility of chromatin modifications, may afford an opportunity for therapeutic intervention following a genetic diagnosis. Development of treatments requires an understanding of protein function and models of the disease. Here, we provide a mouse model of Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS) (OMIM 603736) and demonstrate proof-of-principle efficacy of postnatal treatment. SBBYSS results from heterozygous mutations in the KAT6B (MYST4/MORF/QFK) gene and is characterized by intellectual disability and autism-like behaviors. Using human cells carrying SBBYSS-specific KAT6B mutations and Kat6b heterozygous mice (Kat6b+/–), we showed that KAT6B deficiency caused a reduction in histone H3 lysine 9 acetylation. Kat6b+/– mice displayed learning, memory, and social deficits, mirroring SBBYSS individuals. Treatment with a histone deacetylase inhibitor, valproic acid, or an acetyl donor, acetyl-carnitine (ALCAR), elevated histone acetylation levels in the human cells with SBBYSS mutations and in brain and blood cells of Kat6b+/– mice and partially reversed gene expression changes in Kat6b+/– cortical neurons. Both compounds improved sociability in Kat6b+/– mice, and ALCAR treatment restored learning and memory. These data suggest that a subset of SBBYSS individuals may benefit from postnatal therapeutic interventions.

Authors

Maria I. Bergamasco, Hannah K. Vanyai, Alexandra L. Garnham, Niall D. Geoghegan, Adam P. Vogel, Samantha Eccles, Kelly L. Rogers, Gordon K. Smyth, Marnie E. Blewitt, Anthony J. Hannan, Tim Thomas, Anne K. Voss

×

Figure 6

Kat6b+/– mice show reduced sociability and social recognition.

Options: View larger image (or click on image) Download as PowerPoint
Kat6b+/– mice show reduced sociability and social recognition. (A–J) Th...
(A–J) Three-chamber social test. Session 1: mouse versus empty cage (A–C), session 2: short-term social recognition (1 hour) novel versus familiar mouse (D–F), session 3: long-term social recognition (24 hours) novel versus familiar mouse (G–J). Proportion of time spent around the empty cage and cage with mouse (B). Discrimination index for the mouse over the empty cage (C). Proportion of time spent around the novel mouse and the familiar mouse (E and H). Discrimination index for the novel over the familiar mouse (F and I). Total distance traveled in session 3 of the 3-chamber social test (J). n = 16 Kat6b+/+ (8M/8F) and 15 Kat6b+/– (8-9M/6-7F) mice. Data are represented as mean ± SEM and were analyzed using 2-way ANOVA with Holm-Šidák correction (B, E, and H), 1-sample t test comparing with 0 (C, F, and I), and Student’s t test (J). Circles, triangles, individual female and male mice. Related data in Supplemental Figure 11.